International journal of biological macromolecules · 2025
The potential neuro-oncology link of GALR1 protein molecular mechanism in breast cancer: Expression in BT549 and MDA-MB-231 cells and its role in proliferation and migration.
Источник пометил эту публикацию как отозванную.
СтатьяОтозванная публикацияНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lu Linjie, Chai Xiao, Qin Shuting, Wei Yegang, Zhou Cong, Wei Changyuan, Li Jiehua, Tan Guohe
Аннотация
The role of GALR1 (mannose bioactive peptide receptor 1) in multiple physiological and pathological processes has attracted much attention, especially in the occurrence and development of cancer. The objective of this study was to examine the expression pattern of GALR1 in BT549 (human breast cancer cells) and MDA-MB-231 (invasive breast cancer cells), and to comprehensively assess its function in cell proliferation and migration, with the aim of uncovering the potential neuro-tumor correlation of GALR1 in cancer. Western blot and real-time quantitative PCR were employed to detect the expression of GALR1 in BT549 and MDA-MB-231 cells. The function of GALR1 was evaluated by cell proliferation assay (e.g., MTT assay) and migration assay (e.g., scratch assay and Transwell migration assay). The expression of GALR1 was down-regulated through RNA interference to investigate its specific role in cell proliferation and migration. The expression of GALR1 was significantly up-regulated in BT549 and MDA-MB-231 cells. Downregulation of GALR1 resulted in a significant decrease in cell proliferation capacity, accompanied by a decrease in migration capacity. Further analysis suggests that GALR1 may act by regulating cell cycle-related proteins and migration-related signaling pathways, such as the PI3K/AKT and MAPK/ERK signaling pathways.